Cancer Gene Therapy Market Research Report, Share, and Forecast to 2025Posted by rekha on October 18th, 2019 Precision Business Insights (PBI) in its report titled “Cancer Gene Therapy Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2014-2018 and Forecast 2019-2025” assesses the market performance over seven years forecast period from 2019 to 2025. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period. The cancer gene therapy market size was accounted for US$ XX in 2018 and anticipated to account for US$ 3,287.9 Mn by 2025. Increased prevalence of various cancers such as liver cancer, lung cancer, and breast cancer due to change in lifestyle is a major factor drive the growth of cancer gene therapy market over the forecast years, For instance, according to WHO 2018 data, approximately 9.6 Mn death occurred due to cancer around the globe. Moreover, increase in the alcohol and tobacco consumption, technological advancements in the gene therapy, and government initiation to raise the awareness about cancer diseases are anticipated to propel the cancer gene therapy market over the forecast years. However, high cost for the treatment, lack of sophisticated healthcare infrastructure in underdeveloped countries, and stringent regulatory guidelines for the gene therapy are anticipated to deter the cancer gene therapy market over the future years. Cancer gene therapy market segmented on the basis of therapy type, end user, and region. For request sample : https://www.precisionbusinessinsights.com/request-sample?product_id=16156 Oncolytic Virotherapy Segment Expected to Dominate the Market Based on therapy type, gene induced immunotherapy, oncolytic virotherapy, and gene transfer/gene replacement. Among all the therapies, oncolytic virotherapy dominated the cancer gene therapy market in 2018 and the same trend is expected over the forecast years owing to most effective therapy over all other therapies for in vivo gene transfer. In this therapy, vector targets specific tissue with high transduction efficiency and sustain a stable, regulated gene expression without any side effects or immunogenic responses. North-America, Accounts for Major Revenue Share for Cancer Gene Therapy Market Precision Business Insights (PBI), cancer gene therapy market report analyses the market in different regions North America, Europe, Asia Pacific, Latin America and Middle East and Africa. According to regional analysis, North America accounted for major revenue share due to increased rates of certain types of cancers in U.S. and Canada. For instance, according to National Cancer Institute 208, approximately 1,735,350 cases diagnosed with cancer in U.S. Moreover, rise in R&D for the development of innovative therapies, presence of skilled professionals, and favorable reimbursement policies are anticipated to propel the cancer gene therapy market in the North America region. Europe cancer gene therapy market projected to grow at significant growth rate owing to adoption of advanced therapies, increase in healthcare expenditure, and surge in incidence of cancer in the region. Product Approval and Launch of Advanced Technologies in Cancer Gene Therapy Market In August 2017, Novartis received FDA approval for Kymriah, a cancer gene therapy for certain pediatric and young adult patients with a form of acute lymphoblastic leukemia. Key player’s profiles in the report are Urigen Pharmaceuticals Inc., GenVec, Inc., Oxford BioMedica, Vical, ANI Pharmaceuticals, Inc., Genzyme Corporation, Novartis AG, and Cell Medica (U.K.) Detailed Segmentation By Therapy Type o Gene Induced Immunotherapy
Oncolytic Virotherapy
o Gene Transfer/ Gene Replacement
By End-User o Hospitals o Clinics o Biotechnology Institutes Geography o North America
o Europe
o Asia-Pacific
o Latin America
o Middle East and Africa (MEA)
For more information: https://www.precisionbusinessinsights.com/market-reports/global-cancer-gene-therapy-market/ Like it? Share it! More by this author |